Improving Access to Medications for Opioid Use Disorder (MOUD) - DEA Training (Module 6 of 9)

Biosketch - David R. Neff, D.O. 

David Neff, DO has been in medical practice for 45 years with practical expertise in health policy at the national and local levels and how it impacts access to high-quality patient care. While performing roles in clinical practice, academia, state government, and the pharmaceutical industry, Dr. Neff has been involved in large scale health systems strategy and design projects for chronic pain conditions, addiction and several other disease states. He has been studying the history of opioid use over several millennia and the impact of the current opioid mortality crisis since 2010 and its earliest beginnings in the early 2000’s.

He is an expert on opioid addiction in the age of fentanyl and polysubstance misuse.  He has practical experience with predictive genomics that is applicable to the epigenetics of pain and addiction management. He has chaired several P&T Committees and Drug Utilization Review Boards. He is a founding member of the Michigan Health Society Opioid Safety Collaborative and the Michigan Osteopathic Association’s Presidential Ad Hoc Committee to address the opioid crisis since their inception in 2016.

Dr. Neff frequently lectures on these topics at the state and national level and has engaged in online training to satisfy licensing requirements of the US Medication Access and Training Expansion (MATE) Act of 2022 and for MI licensing requirements. 

Dr. Neff is board certified by American College of Osteopathic Family Physicians and completed a two-year fellowship in Osteopathic Manual Medicine and Clinical Biomechanics. He was appointed to the clinical faculty in the MSUCOM Department of Family and Community Medicine in 1981.